Why did CLTN.SW stock jump pre-market today?

CLTN.SW stock rose **5.90%** pre-market on 18 Feb 2026 due to higher-than-average volume and sector rotation into medical instruments ahead of COLTENE’s earnings on 06 Mar 2026. Early buyers reacted to momentum and improved FY 2024 growth metrics.

What is Meyka AI’s grade for CLTN.SW and what does it mean?

Meyka AI rates CLTN.SW with a score out of 100: **71.90 (B+) — Suggestion: BUY**. The grade considers benchmark and sector comparison, growth, metrics and forecasts. It is informational and not financial advice.

What price targets and risk levels should investors watch for CLTN.SW?

Key levels: support near **CHF54.00**, base target **CHF58.00**, bull target **CHF70.00**, conservative **CHF50.00**. Watch inventory days (**177.27**) and the payout ratio (**1.04**) as downside risks.

How do CLTN.SW valuation metrics compare to peers?

CLTN.SW trades at PE **23.92**, price-to-sales **1.42** and PB **3.81**. PE is below some medical-instrument peers but valuation reflects a mix of stable cash flow and above-average dividend yield **4.36%**.

CH Stocks

CLTN.SW up 5.90% pre-market 18 Feb 2026 (SIX): Monitor at CHF57.40

ByDanny Kontos February 18, 2026February 18, 2026

CLTN.SW stock leads Swiss pre-market movers on 18 Feb 2026 after climbing 5.90% to CHF57.40. The move follows higher-than-normal volume at 16,843 shares versus an average of 5,658, suggesting fresh buying interest. COLTENE Holding AG (CLTN.SW) trades on the SIX in Switzerland in the Healthcare sector. Key drivers include a tight float, improving margins reported in FY 2024 and a near-term earnings date set for 06 Mar 2026. We examine fundamentals, technicals, Meyka AI grading and short-term price scenarios to explain today’s top-gainer status